VANGUARD GROUP INC - 30 Sep 2025 SCHEDULE 13G Report for Avalo Therapeutics Inc Common Stock (AVTX)

Filing Manager
VANGUARD GROUP INC
Reporting Manager
The Vanguard Group
Symbol
AVTX
Shares outstanding
13.2M shares
Disclosed Ownership
693K shares
Ownership
5.26%
Form type
SCHEDULE 13G
Filing time
30 Oct 2025, 14:04:47 UTC
Date of event
30 Sep 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
The Vanguard Group 5.26% 693K 0 55.8K Ashley Grim Head of Global Fund Administration